“ADVANTAGES OF USING LIPOSOME-ENCAPSULATED ANTIBIOTICS TO FIGHT INFECTIONS CAUSED BY ENTEROBACTERIA”. 2024. Journal of Population Therapeutics and Clinical Pharmacology 31 (9): 731-40. https://doi.org/10.53555/nhwgvd87.